AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 237 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,886,650 | +173.3% | 237,389 | +182.2% | 0.11% | +175.0% |
| Q2 2023 | $1,056,384 | -43.2% | 84,107 | -49.8% | 0.04% | -48.1% |
| Q1 2023 | $1,859,205 | +70.4% | 167,647 | +60.4% | 0.08% | +79.1% |
| Q3 2022 | $1,091,000 | +41.1% | 104,500 | +45.1% | 0.04% | +30.3% |
| Q2 2022 | $773,000 | -47.2% | 72,000 | -53.4% | 0.03% | -47.6% |
| Q1 2022 | $1,464,000 | +242.1% | 154,634 | +317.7% | 0.06% | +133.3% |
| Q4 2021 | $428,000 | -47.2% | 37,021 | -54.8% | 0.03% | -64.5% |
| Q1 2021 | $810,000 | – | 81,910 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |